Palboxen 125mg Capsules
Regular price
Rs.0.00 PKR
inc. VAT
Couldn't load pickup availability
You can promote by sharing on social networks on the links.
Product Description
Product Name: Palboxen 125mg Capsules
Product Form: Capsules
Pack Size: 21's
Manufactured By: Everest Pharmaceuticals
Used For:
- Cancer Treatment: Palboxen, also known as Palbociclib, is primarily used for the treatment of certain types of breast cancer, particularly hormone receptor-positive (HR+) and HER2-negative breast cancer. It is typically used in combination with other therapies such as letrozole or an aromatase inhibitor.
Side Effects:
- Bone Marrow Suppression: Decreased blood cell counts, including neutropenia (low white blood cells), anemia (low red blood cells), and thrombocytopenia (low platelets), increasing the risk of infection and bleeding.
- Nausea and Vomiting: Gastrointestinal side effects are common.
- Diarrhea: Frequent bowel movements or loose stools.
- Fatigue: Feeling of tiredness or weakness.
- Mouth Sores: Oral mucositis, which may cause discomfort or pain in the mouth.
- Hair Loss: Some patients may experience thinning or loss of hair.
- Infections: Increased susceptibility to infections due to lower white blood cell counts.
- Liver Enzyme Changes: Elevated liver enzymes may occur, indicating potential liver issues.
Precautions:
- Blood Monitoring: Regular blood tests are needed to monitor blood cell counts and liver function.
- Infection Risk: Patients should be vigilant about signs of infection and seek medical attention if symptoms such as fever, sore throat, or unusual bruising occur.
- Drug Interactions: Palboxen can interact with other medications, including certain antifungals, antibiotics, and anticonvulsants. Inform your healthcare provider about all other medications and supplements you are taking.
- Pregnancy and Breastfeeding: Not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant.
- Liver Function: Patients with liver impairment may require dose adjustments and closer monitoring.